Cipla: $500m North American Sales Boost Possible In Five Years

Going Beyond Respiratory Key As Cipla Discloses Injectables Ambitions

Growth
Cipla is aiming for significant growth in North America • Source: Alamy

More from Business

More from Generics Bulletin